Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nirman Agri Genetics's earnings before interest and taxes (EBIT) for the
six
months ended in Sep. 2025 was ₹150 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was ₹292 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Nirman Agri Genetics's annualizedROC % for the quarter that ended in Sep. 2025 was 27.70%.
Nirman Agri Genetics's annualizedROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 31.94%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Nirman Agri Genetics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 93.10%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Nirman Agri Genetics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nirman Agri Genetics EV-to-EBIT vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nirman Agri Genetics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nirman Agri Genetics's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹292 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nirman Agri Genetics (NSE:NIRMAN) has a EBIT of ₹292 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nirman Agri Genetics.
Is Nirman Agri Genetics' EBIT too high?
Nirman Agri Genetics' current EBIT is ₹292 Mil. Overall, Nirman Agri Genetics has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nirman Agri Genetics' EBIT compare to CTVA and CF?
Nirman Agri Genetics' EBIT of ₹292 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Agriculture company?
A good EBIT depends on the Agriculture industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nirman Agri Genetics. Nirman Agri Genetics's current EBIT is ₹292 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirman Agri Genetics stock overvalued right now?
Based on GuruFocus' analysis, Nirman Agri Genetics (NSE:NIRMAN) is currently considered Possible Value Trap. The stock's GF Value™ is ₹858.05, compared to a current price of ₹40.45 — trading 95.3% below its estimated fair value. The current EBIT is ₹292 Mil. Nirman Agri Genetics' overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nirman Agri Genetics (NSE:NIRMAN), the current EBIT is ₹292 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nirman Agri Genetics (NSE:NIRMAN) Overvalued in 2026?
Based on GuruFocus' analysis, Nirman Agri Genetics stock appears to be undervalued.
The current stock price of ₹40.45 is trading 95.3% below its estimated GF Value™ of ₹858.05.
GuruFocus considers Nirman Agri Genetics to be Possible Value Trap.
Key valuation signals for NSE:NIRMAN:
EBIT: ₹292 Mil
GF Value™: ₹858.05 vs. price of ₹40.45 (95.3% below fair value)
No single metric tells the full story. See the NSE:NIRMAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nirman Agri Genetics Ltd is an organized Agri-Input company in India. It is in the business of production, processing, and marketing of high-quality hybrid seeds, pesticides, and bio-organic. These processes are used for different crops like corn, sunflower, cotton, paddy, grain sorghum, and others. It is engaged in the business of Agriculture Industry, Manufacturing & Processing of seeds. Its geographical segments include Revenue within India includes sales to customers located within India and Revenue outside India includes sales to customers located outside India including Export Benefits or Incentives.
85GF Score
Get the complete analysis for NSE:NIRMAN
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NIRMAN has been successfully added to your 
